ENA

Serial Number 79251923
Registration 5952326
700

Registration Progress

Application Filed
Nov 2, 2018
Under Examination
Approved for Publication
Oct 22, 2019
Published for Opposition
Oct 22, 2019
Registered
Jan 7, 2020

Attorney Assistance

Important Deadline Approaching
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-07)
Due: January 07, 2026 184 days remaining

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
79251923
Registration Number
5952326
Deadline
January 7, 2026
Description
5 Year - Section 71 and 15 Renewal
Filing Date
November 2, 2018
Registration Date
January 7, 2020
Published for Opposition
October 22, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2020
Registration
Registered
Classes
005

Rights Holder

DAIICHI SANKYO COMPANY, LIMITED

03
Address
3-5-1, Nihonbashi Honcho,
Chuo-ku Tokyo 103-8426
JP

Ownership History

DAIICHI SANKYO COMPANY, LIMITED

Original Applicant
03
JP

DAIICHI SANKYO COMPANY, LIMITED

Owner at Publication
03
JP

DAIICHI SANKYO COMPANY, LIMITED

Original Registrant
03
JP

Legal Representation

Attorney
Mark Lebow

USPTO Deadlines

Next Renewal Deadline
184 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-07)
Due Date
January 07, 2026
Grace Period Ends
July 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description
Jan 7, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 3, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED
May 8, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2020 FIMP P FINAL DISPOSITION PROCESSED
Apr 18, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Apr 7, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 7, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 PUBO A PUBLISHED FOR OPPOSITION
Oct 19, 2019 GPNX P NOTIFICATION PROCESSED BY IB
Oct 2, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 17, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2019 RFNT P REFUSAL PROCESSED BY IB
Mar 18, 2019 RFRR P REFUSAL PROCESSED BY MPU
Mar 18, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2019 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 7, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2019 CNRT R NON-FINAL ACTION WRITTEN
Mar 4, 2019 DOCK D ASSIGNED TO EXAMINER
Mar 4, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2019 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 14, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Nucleic acid medicines for use in the treatment and prevention of genetic disorders; synthetic biomolecules, namely, synthetic nucleoside, synthetic nucleotide and synthetic nucleic acid for clinical or medical use in the treatment and prevention of genetic disorders

Classification

International Classes
005